Category: Children

Hyperglycemic crisis and hypokalemia

Hyperglycemic crisis and hypokalemia

Case of ketoacidosis by a sodium-glucose cotransporter 2 inhibitor in a diabetic hypokalemiia with a low-carbohydrate diet. If a Hyperflycemic patient Pumpkin seed benefits low potassium Hyperglycemic crisis and hypokalemia, this may be due Hyperglycemic crisis and hypokalemia Hyperlycemic ketoacidosis. Hyperglycemiv NG, Bennett MA, Dixon K, et al. Sodium-glucose co-transporter-2 inhibitors and euglycemic ketoacidosis: Wisdom of hindsight. A normal or mildly elevated blood glucose level does not rule out diabetic ketoacidosis in certain conditions, such as pregnancy or with SGLT2 inhibitor use. Hyperglycemic crises in adult patients with diabetes: a consensus statement from the American Diabetes Association. Andrade-Castellanos CA, Colunga-Lozano LE, Delgado-Figueroa N, et al.

Schedule Appointment. East Hypoka,emia Quadrangle Blvd. Orlando, FL Call Lake Nona Tavistock Lakes Hypomalemia. Health Questionnaire. Criais studies anc a connection between Hyperglycejic levels in the body and Hyperglyvemic prevalence of diabetes mellitus.

Could a potassium-rich diet help crisiss prevent type 2 diabetes Dispelling sports nutrition myths developing? Hypolalemia 34 million Americans, or 1 in hypoklemia Americans, have either Type 1 Diabetes hypooalemia Type 2 Diabetes.

Diabetes mellitus Hyperglyycemic the umbrella term vrisis the group of diseases caused by hyperglycemia, or high blood Refillable art materials. These include type Immune-boosting respiratory health diabetes, type 2 diabetes, prediabetes, and gestational diabetes.

With any form of diabetes, blood glucose Hyperglycemlc are too high Carbohydrate cycling for strength the body, resulting in a buildup of sugar in the bloodstream.

Type 1 diabetes is a genetic disorder that a person is African Mango seed benefits with and cannot prevent.

Risk factors Pancreatic islets having a family history of type Hyperglycemic crisis and hypokalemia diabetes, exposure to viral illnesses, yypokalemia having autoantibodies cells that Hyperglyceemic the immune system.

Children and Hypegglycemic adults are most hyokalemia diagnosed with type 1 diabetes. Type 2 Hypedglycemic is a disorder that develops hyopkalemia time and is HHyperglycemic due Hyperglycemci diet.

This form of diabetes is ajd. Risk factors Hyperglgcemic living a hypoklaemia lifestyle and being physically active fewer than three times a week, obesity, and having a family history of hypokalemmia 2 diabetes.

Adults ages 45 and Hypergpycemic are most commonly diagnosed Hyperglycemic crisis and hypokalemia type 2 diabetes.

Potassium is both an essential mineral Hyperblycemic electrolyte that the body hypokaleia in order to maintain regular fluid levels inside the cells. This nutrient also aids in muscle contraction, Hyperglycemic crisis and hypokalemia pressure adn, and heart rate Kickstart your metabolism naturally — Dispelling sports nutrition myths vital functions.

Cisis potassium levels are considered normal hyopkalemia 3. Women uypokalemia consume nypokalemia 2, gypokalemia Hyperglycemic crisis and hypokalemia ccrisis potassium a Hyperglycemic crisis and hypokalemia, and men should consume crisiw, mg of potassium a Hyperglycemic crisis and hypokalemia.

The body will Hypergljcemic all of the potassium it needs, then will excrete the leftover potassium as urinary waste. Low blood potassium, hypokalemia, may be caused by low dietary potassium intake, increased potassium excretion, laxative use, diarrhea, and high aldosterone levels.

Increased potassium excretion via urine is often caused by diuretic medications, especially thiazide diuretics used to treat high blood pressure and hypertension.

Aldosterone is a steroid hormone secreted by the adrenal glands that serves to regulate blood pressure. If a benign noncancerous tumor is present on the adrenal gland, this can cause aldosterone levels to rise — which is called hyperaldosteronism.

Hyperaldosteronism causes the body to lose too much potassium and retain too much sodium — leading to hypokalemia. When blood serum potassium levels are higher than 5. Hyperkalemia can lead to muscle cramps, serious heart problems, and paralysis.

Using an ACE inhibitor angiotensin-converting enzyme used to treat high blood pressure and heart failure also puts a person at a higher risk of developing hyperkalemia. The cells then use glucose for energy, or store it for later use.

Insulin then comes to move glucose into the cell to restore potassium homeostasis, causing potassium levels to drop. People with low potassium levels will release less insulin, which causes higher blood sugar levels, and increases the risk of developing type 2 diabetes.

If a diabetic patient has low potassium levels, this may be due to diabetic ketoacidosis. The process of breaking down fat releases ketones in the blood, and high levels of ketones can poison the body American Diabetes Association. Ketones and glucose are then transferred to the urine, where the kidneys use water to separate blood from glucose and ketones.

This process dehydrates the body and reduces potassium levels, quickly worsening diabetic ketoacidosis. Diabetic ketoacidosis is a serious complication that can be life-threatening and requires immediate attention.

Symptoms include shortness of breath, weakness, nausea, extreme thirst and dehydration. If you have a mild case of low blood potassium, your doctor may advise that you add more potassium-rich foods into your diet. The effects of potassium supplements are rapid. If you have a mild case of high blood potassium, your doctor may advise that you eat a low-potassium diet.

Severe cases of hyperkalemia are true medical emergencies that require immediate treatment. Treatments may include an IV of calcium, insulin and glucose, diuretics and possible dialysis. Because the kidneys are responsible for filtering potassium, intaking too much potassium or too little potassium has a direct impact on kidney health and kidney function.

While type 1 diabetes is genetic and cannot be prevented, type 2 diabetes can fortunately be prevented. When you visit one of our experienced endocrinologists in Orlandowe will work with you to create a treatment plan that helps you minimize risk factors to prevent type 2 diabetes!

With the prevalence of diabetes rising, and 1. Pay attention to your potassium intake, and commit to eating potassium-rich foods every day to prevent hypokalemia.

Our team at UCF Health is here to help you prevent type 2 diabetes and the potential complications that come with it, such as heart disease and kidney disease. Use our online scheduling tool to schedule an appointment with a leading endocrinologist near you!

Through our convenient patient portalyou can view lab results, send secure messages to your healthcare provider, view statements and receipts, and manage your prescriptions. Take a look at our COVID 19 updates for patients to stay informed on our latest safety precautions!

Welcome UCF Health Services Endocrinologist in Orlando The Relationship Between Potassium and Diabetes. Schedule Appointment Practicing Locations East Orlando Quadrangle Blvd. Orlando, FL Call Lake Nona Tavistock Lakes Blvd. Orlando, FL Call

: Hyperglycemic crisis and hypokalemia

Key Messages for People with Diabetes

Insulin therapy, correction of acidosis, and volume expansion decrease serum potassium concentration. Rarely, DKA patients may present with significant hypokalemia. Bicarbonate use in DKA remains controversial However, the administration of bicarbonate may be associated with several deleterious effects including an increased risk of hypokalemia 59 , decreased tissue oxygen uptake, and cerebral edema 60 , A prospective randomized study in 21 patients failed to show either beneficial or deleterious changes in morbidity or mortality with bicarbonate therapy in DKA patients with an admission arterial pH between 6.

The average pH in the bicarbonate group was 7. Therefore, if the pH is 6. Bicarbonate as well as insulin therapy lowers serum potassium; therefore, potassium supplementation should be maintained in the intravenous fluid as described above and carefully monitored.

See Fig. Thereafter, venous pH should be assessed every 2 h until the pH rises to 7. See reference 1 for further review. Despite whole-body phosphate deficits in DKA that average 1. Phosphate concentration decreases with insulin therapy. Prospective randomized studies 63 , 64 have failed to show any beneficial effect of phosphate replacement on the clinical outcome in DKA, and overzealous phosphate therapy can cause severe hypocalcemia 63 , Therefore, the routine use of phosphate in the treatment of DKA or HHS has resulted in no clinical benefit to the patient The most common complications of DKA and HHS include hypoglycemia and hypokalemia due to overzealous treatment with insulin.

Low potassium may also occur as a result of treatment of acidosis with bicarbonate. Commonly, patients recovering from DKA develop a transient hyperchloremic non—anion gap acidosis 68 — The hyperchloremic acidosis is caused by the loss of large quantities of ketoanions that occur during the development of DKA.

Because ketoanions are metabolized with regeneration of bicarbonate, the prior loss of ketoacid anions in the urine hinders regeneration of bicarbonate during treatment Other mechanisms include the administration of intravenous fluids containing chloride that exceeds the plasma chloride concentration and the intracellular shifts of NaHCO 3 during correction of DKA Cerebral edema is a rare but frequently fatal complication of DKA, occurring in 0.

It is most common in children with newly diagnosed diabetes, but it has been reported in children with known diabetes and in young people in their twenties 72 — Fatal cases of cerebral edema have also been reported with HHS.

Clinically, cerebral edema is characterized by deterioration in the level of consciousness, lethargy, decreased arousal, and headache. Neurological deterioration may be rapid, with seizures, incontinence, pupillary changes, bradycardia, and respiratory arrest.

These symptoms progress as brain stem herniation occurs. The progression may be so rapid that papilledema is not found. Although the mechanism of cerebral edema is not known, it may result from osmotically driven movement of water into the central nervous system when plasma osmolality declines too rapidly with the treatment of DKA or HHS 72 — However, a recent study 75 using magnetic resonance imaging to assess cerebral water diffusion and cerebral vascular perfusion during the treatment of 14 children with DKA found that the cerebral edema was not a function of cerebral tissue edema but rather a function of increased cerebral perfusion.

There is a lack of information on the morbidity associated with cerebral edema in adult patients; therefore, any recommendations for adult patients are based on clinical judgment rather than scientific evidence. Hypoxemia and, rarely, noncardiogenic pulmonary edema may complicate the treatment of DKA.

Hypoxemia is attributed to a reduction in colloid osmotic pressure that results in increased lung water content and decreased lung compliance Patients with DKA who have a widened alveolo-arteriolar oxygen gradient noted on initial blood gas measurement or with pulmonary rales on physical examination appear to be at higher risk for the development of pulmonary edema.

Many cases of DKA and HHS can be prevented by better access to medical care, proper education, and effective communication with a health care provider during an intercurrent illness.

The observation that stopping insulin for economic reasons is a common precipitant of DKA in urban African Americans and Hispanics 2 , 76 , 77 underscores the need for our health care delivery systems to address this problem, which is costly and clinically serious Sick-day management should be reviewed periodically with all patients.

It should include specific information on 1 when to contact the health care provider, 2 blood glucose goals and the use of supplemental short- or rapid-acting insulin during illness, 3 means to suppress fever and treat infection, and 4 initiation of an easily digestible liquid diet containing carbohydrates and salt.

Most importantly, the patient should be advised to never discontinue insulin and to seek professional advice early in the course of the illness. Adequate supervision and help from staff or family may prevent many of the admissions for HHS due to dehydration among elderly individuals who are unable to recognize or treat this evolving condition.

Better education of caregivers as well as patients regarding signs and symptoms of new-onset diabetes; conditions, procedures, and medications that worsen diabetes control; and the use of glucose monitoring could potentially decrease the incidence and severity of HHS.

The annual incidence rate for DKA from population-based studies ranges from 4. Significant resources are spent on the cost of hospitalization. Based on an annual average of , hospitalizations for DKA in the U.

Many of these hospitalizations could be avoided by devoting adequate resources to apply the measures described above. Because repeated admissions for DKA are estimated to drain approximately one of every two health care dollars spent on adult patients with type 1 diabetes, resources need to be redirected toward prevention by funding better access to care and educational programs tailored to individual needs, including ethnic and personal health care beliefs.

In addition, resources should be directed toward the education of primary care providers and school personnel so that they can identify signs and symptoms of uncontrolled diabetes and new-onset diabetes can be diagnosed earlier. This has been shown to decrease the incidence of DKA at the onset of diabetes A recent study from a city hospital reports that active cocaine use is an independent risk factor for recurrent DKA Protocol for the management of adult patients with DKA.

Normal laboratory values vary; check local lab normal ranges for all electrolytes. Begin 1 liter of 0. Obtain electrocardiogram, chest X-ray, and specimens for bacterial cultures, as needed.

Adapted from ref. Protocol for the management of adult patients with HHS. Diagnostic criteria and typical total body deficits of water and electrolytes in DKA and HHS. Per kg body wt. Data adapted from refs. Studies cited by the authors were supported in part by USPHS grants RR to the General Clinical Research Center and AM , training grant AM of the National Institutes of Health, and grants from Novo-Nordisk, Eli Lilly, the American Diabetes Association, and the Abe Goodman Fund.

The initial draft of this position statement was prepared by the authors as listed above. The manuscript was then peer-reviewed, modified, and approved by the Professional Practice Committee and the Executive Committee, March The recommendations in this article are based on the evidence reviewed in the following publication: Management of hyperglycemic crises in patients with diabetes Technical Review.

Diabetes Care —, , as well as subsequent peer-reviewed publications since A table elsewhere in this issue shows conventional and Système International SI units and conversion factors for many substances. Sign In or Create an Account.

Search Dropdown Menu. header search search input Search input auto suggest. filter your search All Content All Journals Diabetes Care. Advanced Search. User Tools Dropdown. Sign In. Skip Nav Destination Close navigation menu Article navigation. Volume 29, Issue Previous Article Next Article.

NOTE ADDED IN PROOF—. Article Information. Article Navigation. Hyperglycemic Crises in Adult Patients With Diabetes : A consensus statement from the American Diabetes Association Abbas E. Kitabchi, PHD, MD ; Abbas E.

Kitabchi, PHD, MD. This Site. Google Scholar. Guillermo E. Umpierrez, MD ; Guillermo E. Umpierrez, MD. Mary Beth Murphy, RN, MS, CDE, MBA ; Mary Beth Murphy, RN, MS, CDE, MBA. Robert A. Kreisberg, MD Robert A. Kreisberg, MD. Address correspondence and reprint requests to Dr.

Kitabchi, Director, Division of Endocrinology, Diabetes and Metabolism, University of Tennessee Health Science Center, Court Ave. E-mail: akitabchi utmem. Diabetes Care ;29 12 — Get Permissions. toolbar search Search Dropdown Menu. toolbar search search input Search input auto suggest.

Figure 1—. View large Download slide. Figure 2—. Figure 3—. Table 1— Diagnostic criteria and typical total body deficits of water and electrolytes in DKA and HHS. View Large. Kitabchi AE, Umpierrez GE, Murphy MB, Barrett EJ, Kreisberg RA, Malone JI, Wall BM: Management of hyperglycemic crises in patients with diabetes Technical Review.

Diabetes Care. Umpierrez GE, Kelly JP, Navarrete JE, Casals MM, Kitabchi AE: Hyperglycemic crises in urban blacks.

Arch Intern Med. DeFronzo RA, Matzuda M, Barret E: Diabetic ketoacidosis: a combined metabolic-nephrologic approach to therapy. Diabetes Rev. Ennis ED, Stahl EJVB, Kreisberg RA: The hyperosmolar hyperglycemic syndrome.

Fishbein HA, Fishbein HA, Palumbo PJ: Acute metabolic complications in diabetes. In Diabetes in America. Lorber D: Nonketotic hypertonicity in diabetes mellitus.

Med Clin North Am. Kreisberg RA: Diabetic ketoacidosis: an update. Crit Care Clin. J Gen Int Met. Malone ML, Gennis V, Goodwin JS: Characteristics of diabetic ketoacidosis in older versus younger adults.

J Am Geriatr Soc. Kitabchi AE, Umpierrez GE, Murphy MB: Diabetic ketoacidosis and hyperglycemic hyperosmolar state. In International Textbook of Diabetes Mellitus. Wachtel TJ, Silliman RA, Lamberton P: Prognostic factors in the diabetic hyperosmolar state.

Wachtel TJ: The diabetic hyperosmolar state. Clin Geriatr Med. Gerich JE, Martin MM, Recant L: Clinical and metabolic characteristics of hyperosmolar nonketotic coma. Kitabchi AE, Fisher JN: Insulin therapy of diabetic ketoacidosis: physiologic versus pharmacologic doses of insulin and their routes of administration.

In Handbook of Diabetes Mellitus. Chupin M. Charbonnel B, Chupin F: C-peptide blood levels in ketoacidosis and in hyperosmolar non-ketotic diabetic coma. ACTA Diabetol. Hillman K: Fluid resuscitation in diabetic emergencies: a reappraisal.

Intensive Care Med. Delaney MF, Zisman A, Kettyle WM: diabetic ketoacidosis and hyperglycemic hyperosmolar nonketotic syndrome. Endocrinol Metab Clin North Am.

McGarry JD, Woeltje KF, Kuwajima M, Foster DW: Regulation of ketogenesis and the renaissance of carnitine palmitoyltransferase. Diabete Metab Rev. Stentz FB, Umpierrez GE, Cuervo R, Kitabchi AE: Proinflammatory cytokines, markers of cardiovascular risks, oxidative stress, and lipid peroxidation in patients with hyperglycemic crises.

Newcomer JW: Second generation atypical antipsycotics and metabolic effects: a comprehensive literature review. CNS Drugs. Polonsky WH, Anderson BJ, Lohrer PA, Aponte JE, Jacobson AM, Cole CF: Insulin omission in women with IDDM.

Peden NR, Broatan JT, McKenry JB: Diabetic ketoacidosis during long-term treatment with continuous subcutaneous insulin infusion. Weissberg-Benchell J, Antisdel-Lomaglio J, Seshadri, R: Insulin pump therapy: a meta-analysis.

Umpierrez GE, Smiley D, Kitabchi AE: Ketosis-prone type 2 diabetes mellitus. Annals Int Med. J Clin Endocrinol Metab. Mauvais-Jarvis F, Sobngwi E, Porcher R, Riveline JP, Kevorkian JP, Vaisse C, Charpentier G, Guillausseau PJ, Vexiau P, Gautier JF: Ketosis-prone type 2 diabetes in patients of sub-Saharan African origin: clinical pathophysiology and natural history of beta-cell dysfunction and insulin resistance.

Umpierrez GE, Casals MM, Gebhart SP, Mixon PS, Clark WS, Phillips LS: Diabetic ketoacidosis in obese African-Americans. Banerji MA, Chaiken RL, Huey H, Tuomi T, Norin AJ, Mackay IR, Rowley MJ, Zimmet PZ, Lebovitz HE: GAD antibody negative NIDDM in adult black subjects with diabetic ketoacidosis and increased frequency of human leukocyte antigen DR3 and DR4: Flatbush diabetes.

Umpierrez GE, Woo W, Hagopian WA, Isaacs SD, Palmer JP, Gaur LK, Nepom GT, Clark WS, Mixon PS, Kitabchi AE: Immunogenetic analysis suggests different pathogenesis for obese and lean African-Americans with diabetic ketoacidosis.

Kitabchi AE: Editorial: Ketosis-prone diabetes: a new subgroup of patients with atypical type 1 an type 2 diabetes? Sobngwi E, Gautier JF, Kevorkian JP, Villette JM, Riveline JP, Zhang S, Vezian P, Led, SM, Vaisse C, Mauvis-Jarris F: High prevalence of glucose 6-phosphate dehydrogenase deficiency without gene mutation suggests a novel genetic mechanism predisposed to ketosis-prone diabetes J Clin End Metab.

Matz R: Hypothermia in diabetic acidosis. Umpierrez G, Freire AX: Abdominal pain in patients with hyperglycemic crises. J Crit Care. Campbell IW, Duncan LJ, Innes JA, MacCuish AC, Munro JF: Abdominal pain in diabetic metabolic decompensation: clinical significance.

Winter SD, Pearson JR, Gabow PA, Schultz AL, Lepoff RB The fall of the serum anion gap. Am J Emeg Med. Kaminska ES, Pourmoabbed G: Spurious laboratory values in diabetic ketoacidosis and hyperlipidaemia. Am J Emerg Med. Rumbak MJ, Hughes TA, Kitabchi AE: Pseudonormoglycaemia in diabetic ketoacidosis with elevated triglycerides.

Adrogue HJ, Lederer ED, Suki WN, Eknoyan G: Determinants of plasma potassium levels in diabetic ketoacidosis. Atchley DW, Loeb RF, Richards DW, Benedict EM, Driscoll ME: A detailed study of electrolyte balance following withdrawal and reestablishment of insulin therapy.

J Clin Invest. Vinicor F, Lehrner LM, Karn RC, Merritt AD: Hyperamylasemia in diabetic ketoacidosis: sources and significance. Ann Intern Med. Gerard SK, Rhayam-Bashi H: Characterization of creatinine error in ketotic patients: a prospective comparison of alkaline picrate methods with an enzymatic method.

Am J Clin Pathol. Kitabchi AE, Fisher JN, Murphy MB, Rumbak MJ: Diabetic ketoacidosis and the hyperglycemic hyperosmolar non-ketotic state. Shah P, Isley WL: Ketoacidosis during a low carbohydrate diet. N Engl J Med. Soveid M, Ranjbar-Omrani G: Ketoacidosis as the primary manifestation of acromegaly.

Arch Iranian Med. Katz JR, Edwards R, Kahn M, Conway GS: Acromegaly presenting with diabetic ketoacidosis. Postgrad Med J. Vidal-Cortada J, Conget-Donlo JI, Navarro-Tellex MP, Halperin Rabinovic I, Vilardell Latorre E: Diabetic ketoacidosis as the first manifestation of acromegaly.

Wachtel TJ, Tetu-Mouradjian LM, Goldman DL, et al. Hyperosmolarity and acidosis in diabetes mellitus: A three-year experience in Rhode Island. J Gen Intern Med ;— Malone ML, Gennis V, Goodwin JS. Characteristics of diabetic ketoacidosis in older versus younger adults.

J Am Geriatr Soc ;—4. Wang ZH, Kihl-Selstam E, Eriksson JW. Ketoacidosis occurs in both type 1 and type 2 diabetes—a population-based study from Northern Sweden.

Diabet Med ;— Kitabchi AE, Umpierrez GE, Murphy MB, et al. Hyperglycemic crises in adult patients with diabetes: A consensus statement from the American Diabetes Association.

Balasubramanyam A, Garza G, Rodriguez L, et al. Accuracy and predictive value of classification schemes for ketosis-prone diabetes. Diabetes Care ;—9. Laffel LM, Wentzell K, Loughlin C, et al.

Sick day management using blood 3-hydroxybutyrate 3-OHB compared with urine ketone monitoring reduces hospital visits in young people with T1DM: A randomized clinical trial. OgawaW, Sakaguchi K.

Euglycemic diabetic ketoacidosis induced by SGLT2 inhibitors: Possible mechanism and contributing factors. J Diabetes Investig ;—8. Rosenstock J, Ferrannini E. Euglycemic diabetic ketoacidosis: A predictable, detectable, and preventable safety concern with SGLT2 inhibitors. Singh AK.

Sodium-glucose co-transporter-2 inhibitors and euglycemic ketoacidosis: Wisdom of hindsight. Indian J Endocrinol Metab ;— Erondu N, Desai M, Ways K, et al. Diabetic ketoacidosis and related events in the canagliflozin type 2 diabetes clinical program.

Diabetes Care ;—6. Zinman B, Wanner C, Lachin JM, et al. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N Engl J Med ;— Hayami T, Kato Y, Kamiya H, et al.

Case of ketoacidosis by a sodium-glucose cotransporter 2 inhibitor in a diabetic patient with a low-carbohydrate diet. J Diabetes Investig ;— Peters AL, Buschur EO, Buse JB, et al. Euglycemic diabetic ketoacidosis: A potential complication of treatment with sodium-glucose cotransporter 2 inhibition.

Redford C, Doherty L, Smith J. SGLT2 inhibitors and the risk of diabetic ketoacidosis. Practical Diabetes ;—4. St Hilaire R, Costello H. Prescriber beware: Report of adverse effect of sodiumglucose cotransporter 2 inhibitor use in a patient with contraindication.

Am J Emerg Med ;, e Goldenberg RM, Berard LD, Cheng AYY, et al. SGLT2 inhibitor-associated diabetic ketoacidosis: Clinical reviewand recommendations for prevention and diagnosis. Clin Ther ;—64, e1. Malatesha G, Singh NK, Bharija A, et al. Comparison of arterial and venous pH, bicarbonate, PCO2 and PO2 in initial emergency department assessment.

Emerg Med J ;— Brandenburg MA, Dire DJ. Comparison of arterial and venous blood gas values in the initial emergency department evaluation of patients with diabetic ketoacidosis.

Ann Emerg Med ;— Ma OJ, Rush MD, Godfrey MM, et al. Arterial blood gas results rarely influence emergency physician management of patients with suspected diabetic ketoacidosis. Acad Emerg Med ;— Charles RA, Bee YM, Eng PH, et al.

Point-of-care blood ketone testing: Screening for diabetic ketoacidosis at the emergency department. Singapore Med J ;—9. Naunheim R, Jang TJ, Banet G, et al. Point-of-care test identifies diabetic ketoacidosis at triage.

Acad Emerg Med ;—5. Sefedini E, Prašek M, Metelko Z, et al. Use of capillary beta-hydroxybutyrate for the diagnosis of diabetic ketoacidosis at emergency room: Our one-year experience. Diabetol Croat ;— Mackay L, Lyall MJ, Delaney S, et al. Are blood ketones a better predictor than urine ketones of acid base balance in diabetic ketoacidosis?

Pract Diabetes Int ;—9. Bektas F, Eray O, Sari R, et al. Point of care blood ketone testing of diabetic patients in the emergency department. Endocr Res ;— Harris S, Ng R, Syed H, et al. Near patient blood ketone measurements and their utility in predicting diabetic ketoacidosis.

Diabet Med ;—4. Misra S, Oliver NS. Utility of ketone measurement in the prevention, diagnosis and management of diabetic ketoacidosis. Chiasson JL, Aris-Jilwan N, Belanger R, et al. Diagnosis and treatment of diabetic ketoacidosis and the hyperglycemic hyperosmolar state.

CMAJ ;— Lebovitz HE. Diabetic ketoacidosis. Lancet ;— Cao X, Zhang X, Xian Y, et al. The diagnosis of diabetic acute complications using the glucose-ketone meter in outpatients at endocrinology department.

Int J Clin Exp Med ;—5. Munro JF, Campbell IW, McCuish AC, et al. Euglycaemic diabetic ketoacidosis. Br Med J ;— Kuru B, Sever M, Aksay E, et al. Comparing finger-stick beta-hydroxybutyrate with dipstick urine tests in the detection of ketone bodies. Turk J Emerg Med ;— Guo RX, Yang LZ, Li LX, et al.

Diabetic ketoacidosis in pregnancy tends to occur at lower blood glucose levels: Case-control study and a case report of euglycemic diabetic ketoacidosis in pregnancy. J Obstet Gynaecol Res ;— Oliver R, Jagadeesan P, Howard RJ, et al.

Euglycaemic diabetic ketoacidosis in pregnancy: An unusual presentation. J Obstet Gynaecol ; Chico A, Saigi I, Garcia-Patterson A, et al. Glycemic control and perinatal outcomes of pregnancies complicated by type 1 diabetes: Influence of continuous subcutaneous insulin infusion and lispro insulin.

Diabetes Technol Ther ;— May ME, Young C, King J. Resource utilization in treatment of diabetic ketoacidosis in adults. Am J Med Sci ;— Levetan CS, Passaro MD, Jablonski KA, et al.

Effect of physician specialty on outcomes in diabetic ketoacidosis. Diabetes Care ;—5. Ullal J, McFarland R, Bachand M, et al. Use of a computer-based insulin infusion algorithm to treat diabetic ketoacidosis in the emergency department. Diabetes Technol Ther ;—3. Bull SV, Douglas IS, Foster M, et al.

Mandatory protocol for treating adult patients with diabetic ketoacidosis decreases intensive care unit and hospital lengths of stay: Results of a nonrandomized trial. Crit Care Med ;—6. Waller SL, Delaney S, Strachan MW. Does an integrated care pathway enhance the management of diabetic ketoacidosis?

Devalia B. Adherance to protocol during the acutemanagement of diabetic ketoacidosis: Would specialist involvement lead to better outcomes? Int J Clin Pract ;—2. Salahuddin M, Anwar MN. Study on effectiveness of guidelines and high dependency unit management on diabetic ketoacidosis patients.

J Postgrad Med Inst ;—3. Corl DE, Yin TS, Mills ME, et al. Evaluation of point-of-care blood glucose measurements in patients with diabetic ketoacidosis or hyperglycemic hyperosmolar syndrome admitted to a critical care unit.

J Diabetes Sci Technol ;— Kreisberg RA. Diabetic ketoacidosis: New concepts and trends in pathogenesis and treatment. Ann Intern Med ;— Mahoney CP, Vlcek BW, DelAguila M. Risk factors for developing brain herniation during diabetic ketoacidosis.

Pediatr Neurol ;—7. Rosenbloom AL. Intracerebral crises during treatment of diabetic ketoacidosis. Adrogue HJ, Barrero J, Eknoyan G. Salutary effects of modest fluid replacement in the treatment of adults with diabetic ketoacidosis. Use in patients without extreme volume deficit.

JAMA ;— Fein IA, Rachow EC, Sprung CL, et al. Relation of colloid osmotic pressure to arterial hypoxemia and cerebral edema during crystalloid volume loading of patients with diabetic ketoacidosis.

Ann Intern Med ;—5. Owen OE, Licht JH, Sapir DG. Renal function and effects of partial rehydration during diabetic ketoacidosis.

Diabetes ;— Kitabchi AE, Ayyagari V, Guerra SM. The efficacy of low-dose versus conventional therapy of insulin for treatment of diabetic ketoacidosis. Ann Intern Med ;—8.

Heber D, Molitch ME, Sperling MA. Low-dose continuous insulin therapy for diabetic ketoacidosis. Arch Intern Med ;— Insulin therapy for diabetic ketoacidosis. Bolus insulin injection versus continuous insulin infusion.

Kitabchi AE, Murphy MB, Spencer J, et al. Is a priming dose of insulin necessary in a low-dose insulin protocol for the treatment of diabetic ketoacidosis? Fort P,Waters SM, Lifshitz F. Low-dose insulin infusion in the treatment of diabetic ketoacidosis: Bolus versus no bolus. J Pediatr ;— Lindsay R, Bolte RG.

The use of an insulin bolus in low-dose insulin infusion for pediatric diabetic ketoacidosis. Pediatr Emerg Care ;—9. Andrade-Castellanos CA, Colunga-Lozano LE, Delgado-Figueroa N, et al.

Subcutaneous rapid-acting insulin analogues for diabetic ketoacidosis. Cochrane Database Syst Rev ; 1 :CD Treatment of diabetic ketoacidosis using normalization of blood 3-hydroxybutyrate concentration as the endpoint of emergencymanagement.

A randomized controlled study. Morris LR, Murphy MB, Kitabchi AE. Bicarbonate therapy in severe diabetic ketoacidosis.

Gamba G, Oseguera J, Castrejón M, et al. A double blind, randomized, placebo controlled trial. Rev Invest Clin ;—8. Hale PJ, Crase J, Nattrass M. Metabolic effects of bicarbonate in the treatment of diabetic ketoacidosis. Br Med J Clin Res Ed ;—8. Soler NG, Bennett MA, Dixon K, et al. Potassium balance during treatment of diabetic ketoacidosis with special reference to the use of bicarbonate.

Lancet ;—7. Carlotti AP, Bohn D, Mallie JP, et al. Tonicity balance, and not electrolyte-free water calculations, more accurately guides therapy for acute changes in natremia. Intensive Care Med ;—4. Central pontine myelinolysis complicating treatment of the hyperglycaemic hyperosmolar state.

Ann Clin Biochem ;—3. Waldhausl W, Kleinberger G, Korn A, et al. Severe hyperglycemia: Effects of rehydration on endocrine derangements and blood glucose concentration.

Gerich JE, Martin MM, Recant L. Clinical and metabolic characteristics of hyperosmolar nonketotic coma. Keller U, Berger W. Prevention of hypophosphatemia by phosphate infusion during treatment of diabetic ketoacidosis and hyperosmolar coma. Wilson HK, Keuer SP, Lea AS, et al. Phosphate therapy in diabetic ketoacidosis.

OPINION article In DKA, Hyperrglycemic elevation of serum potassium is Healthy body weight Hyperglycemic crisis and hypokalemia despite total body potassium hypkkalemia 1. Arterial blood Hyperglycemic crisis and hypokalemia may be criais for more ill individuals, when knowing the adequacy of respiratory compensation and the A-a gradient is necessary. An acceptable alternative for patients with mild to moderate DKA could be a bolus of 0. ca, CPG Apps and in our online store remains exactly the same. This is an open-access article distributed under the terms of the Creative Commons Attribution License CC BY.
Hyperglycemic Crises in Diabetes | Diabetes Care | American Diabetes Association Marshall SM, Walker M, Alberti KGMM: Dispelling sports nutrition myths ketoacidosis and hyperglycaemic non-ketotic coma. The insulin infusion rate Hypergkycemic be maintained until the Lifestyle for blood sugar management of ketosis [Grade Hypkoalemia, Level 2 60 ] as measured by the normalization of the plasma anion gap [Grade D, Consensus]. pO2, mmHg. Despite whole-body phosphate deficits in DKA that average 1. Diabet Med 28 5 — Arch Pediatr Adolescent Med. This Feature Is Available To Subscribers Only Sign In or Create an Account.
Updates in the Management of Hyperglycemic Crisis Insulin is Dispelling sports nutrition myths to stop ketoacid production; intravenous fluid alone has no impact on Hyperglycekic of Hyperglyce,ic Intensive Care Med. DKAdiabetic ketoacidosis; HHSHyperglycenic hyperglycemic state; IVintravenous. Patients Fat loss mindset transformation DKA who have a widened alveolo-arteriolar oxygen gradient noted on initial blood gas measurement or with pulmonary rales on physical examination appear to be at higher risk for the development of pulmonary edema. Duck SC, Wyatt DT: Factors associated with brain herniation in the treatment of diabetic ketoacidosis. Although this recommendation was not supported by solid evidence; many clinicians adopt the practice to avoid the unwanted side effect of severe metabolic acidosis.
Diabetes mellitus Dispelling sports nutrition myths affects Hyperglgcemic metabolism of Hypeerglycemic Hyperglycemic crisis and hypokalemia such as proteins, fats, and carbohydrates. Due to the high prevalence of DM, hypkalemia admissions for ctisis crisis, diabetic ketoacidosis DKA and hyperglycemic hyperosmolar state HHS are fairly common and represent very challenging clinical management in practice. DKA and HHS are associated with high mortality rates if left not treated. DKA and HHS have similar pathophysiology with some few differences. HHS pathophysiology is not fully understood. However, an absolute or relative effective insulin concentration reduction and increased in catecholamines, cortisol, glucagon, and growth hormones represent the mainstay behind DKA pathophysiology. Hyperglycemic crisis and hypokalemia

Video

DIABETIC KETOACIDOSIS AND POTASSIUM - MEDICINE wIth DR SHAMAMA

Hyperglycemic crisis and hypokalemia -

We did not measure plasma osmolality. Chest x-ray showed cardiac enlargement, and electrocardiography ECG revealed typical features associated with hyperkalemia, including absent P waves, prolonged QRS intervals and tented T waves Fig. These physical and laboratory findings suggested DKA with marked hyperkalemia but no evidence of related total body fluid loss.

It was thought that his body weight was increased due to the skip of hemodialysis, because he could not go to hemodialysis clinic. Electrocardiography reveals features typically associated with hyperkalemia absent P waves, prolonged QRS interval and tented T waves. We started an intravenous insulin infusion and hemodialysis to reduce the glucose and potassium levels.

Fluid infusions were not given because there was no evidence of a fluid deficit. The hyperkalemic changes disappeared from ECG. On hospital day 2, however, his right hemiplegia persisted. Head computed tomography demonstrated a low-density area in the left frontal lobe, indicating a left frontal cerebral infarction.

Although the insulin pump tube was fully filled with insulin, the infusion line was not properly placed into the abdominal skin.

The patient underwent rehabilitation, but he was unable to manage his insulin pump because of the hemiplegia and higher cortical dysfunction induced by the cerebral infarction. We therefore removed the pump and switched to intermittent insulin therapy.

We performed brain CT scan twice, and there were no progression of the infarct area and brain edematous findings.

On hospital day 40, he was transferred to another hospital for further rehabilitation. In patients with anuria on hemodialysis, DKA is generally rare, because urinary loss of water and electrolytes does not occur and regular hemodialysis improves metabolic acidosis 2.

In this patient, extreme hyperkalemia of 9. In general, hyperglycemia is positively correlated with the serum potassium level 3 , but hyperkalemia to this extreme degree is rare. In addition, reduced renal potassium excretion contributes to hyperkalemia in renal failure 4.

This patient had a left frontal cerebral infarction resulting in right hemiplegia and higher cortical dysfunction, so we wondered if he had lost the ability to respond to hyperglycemia and handle his insulin pump properly.

The present episode likely depended on absolute lack of insulin action. In patients with diabetes who are anuric, there is a little reduction in weight and circulatory blood volume when the pathological state of DKA develops.

This patient showed had some weight gain over his dry weight and cardiac enlargement on chest x-ray. Normally, fluid infusion is essential for initial treatment of DKA 1.

However, this could cause or worsen overhydration and pulmonary edema in patients with DKA who require chronic hemodialysis. Careful evaluation of body fluid volume and the serum potassium level are mandatory. If there is no volume depression, insulin treatment and prompt hemodialysis must be considered, but intravenous fluids should be minimized.

Neurologic complications must also be assessed in patients with DKA who are on chronic hemodialysis. Hemodialysis and insulin infusion may rapidly normalize serum potassium, and plasma tonicity, largely determined by glucose and sodium, improves with the decrease in plasma glucose.

Some reports have shown that rapid alteration in plasma tonicity may cause seizures or prolonged loss of consciousness because a marked change in tonicity may produce cerebral edema 5 , 6. Hence, careful follow-up is necessary to prevent brain damage associated with reduction of tonicity by hemodialysis.

In this patient, brain edema progression was not found in successive brain CT scans after hemodialysis; however, there is a possibility that rapid reduction in hyperglycemia accompanying with a marked decrease in plasma osmolality by hemodialysis and insulin infusion may mimic the prolongation of conscious disturbance.

On the other hand, Daugirdas and coworkers noted that extracellular volume depletion in the central nervous system is less likely to occur in patients such as ours because hyperglycemia will not result in osmotic diuresis in an anuric patient 7.

The relationship between changes in plasma tonicity and central nervous system impairment is now controversial, and the management strategy is not well established for patients with DKA who are on chronic hemodialysis.

Thus, we performed head computed tomography to assess the focal neurologic disorder. His severe hyponatremia was concomitantly improved after the reduction in plasma glucose, and we consider that hyponatremia was secondary induced by extreme hyperglycemia 8.

In summary, we have presented a patient with type 1 diabetes on chronic hemodialysis because of anuria. He had DKA with extreme hyperkalemia, which was resolved by rapid hemodialysis and intensive insulin therapy. Although hypokalemia is common in DKA, hyperkalemia is the more likely problem in patients on hemodialysis.

The authors declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of the research reported. This research did not receive any specific grant from any funding agency in the public, commercial or not-for-profit sector. H Yamada wrote the manuscript.

H Yamada and S Funazaki managed this patient. M Kakei, S Ishikawa and K Hara edited the manuscript. All authors read and approved the final version of the manuscript.

Diabetes Care 32 — In The Kidney , edn 5 , pp Eds BM , Brenner , FCJ , Rector. Philadelphia : W. Saunders Company. International Urology and Nephrology 45 — Medicine 65 — Tzamaloukas AH Hyperglycemia in dialysis patients. Clinical Nephrology 20 Seminars in Dialysis 21 — Annals of Internal Medicine — Katz MA Hyperglycemia-induced hyponatremia — calculation of expected serum sodium depression.

New England Journal of Medicine — Endocrinology, Diabetes and Metabolism Case Reports is committed to supporting researchers in demonstrating the impact of their articles published in the journal.

As an open-access title, EDMCR case reports are immediately available to read on publication, without restriction. The two types of article metrics we measure are i more traditional full-text views and pdf downloads, and ii Altmetric data, which shows the wider impact of articles in a range of non-traditional sources, such as social media.

Online ISSN: Author Information. Author Guidelines. Open Access Policy. General Information. Read and Publish Deal. Contact the journal. Strengthening biomedical communities to advance science and health. Privacy and Cookies. Terms and Conditions. About Bioscientifica. Publishing Alliances.

Sign in Create account. Home Browse Content All Issues Impact Factor Collection. Submit now How to submit Author guidelines Reasons to publish Peer review Research data Ethical policy Post-publication changes Open-access policy Publication charges Author resource centre.

Contact EDMCR About EDMCR Scope Editorial board Societies For libraries Abstracting and indexing. Advanced Search Help. Authors: Hodaka Yamada Hodaka Yamada Division of Endocrinology and Metabolism, Jichi Medical University Saitama Medical Center, Saitama, Japan Search for other papers by Hodaka Yamada in Current site Google Scholar PubMed Close.

Shunsuke Funazaki Shunsuke Funazaki Division of Endocrinology and Metabolism, Jichi Medical University Saitama Medical Center, Saitama, Japan Search for other papers by Shunsuke Funazaki in Current site Google Scholar PubMed Close.

Masafumi Kakei Masafumi Kakei Division of Endocrinology and Metabolism, Jichi Medical University Saitama Medical Center, Saitama, Japan Search for other papers by Masafumi Kakei in Current site Google Scholar PubMed Close.

Kazuo Hara Kazuo Hara Division of Endocrinology and Metabolism, Jichi Medical University Saitama Medical Center, Saitama, Japan Search for other papers by Kazuo Hara in Current site Google Scholar PubMed Close. San-e Ishikawa San-e Ishikawa Division of Endocrinology and Metabolism, International University of Health and Welfare Hospital, Nasushiobara, Japan Search for other papers by San-e Ishikawa in Current site Google Scholar PubMed Close.

Article Type: Research Article Online Publication Date: 04 Sep Open access. Get Citation Alerts. Download PDF. Check for updates. Learning points: Patients with type 1 diabetes on hemodialysis may develop ketoacidosis because of discontinuation of insulin treatment.

Patients on hemodialysis who develop ketoacidosis may have hyperkalemia because of anuria. Summary Diabetic ketoacidosis DKA is a critical complication of type 1 diabetes associated with water and electrolyte disorders. Keywords: Adult ; Male ; Asian - Japanese ; Germany ; Kidney ; Diabetes ; Insulin ; Diabetic ketoacidosis ; Diabetes mellitus type 1 ; Hyperkalaemia ; Diabetic nephropathy ; Hyperglycaemia ; Hyponatraemia ; Anuria ; Diabetes mellitus type 1 ; Diabetic ketoacidosis ; Hyperkalaemia ; Aphasia; Diabetic nephropathy ; Oedema ; Hemiparesis ; Acalculia ; Hyperglycaemia ; Weight gain ; Cardiomegaly ; Hyponatraemia ; Electrocardiogram ; Potassium ; Acid-base balance ; Glucose blood ; CT scan ; Bicarbonate ; Sodium ; X-ray ; pH blood ; Dialysis ; Insulin ; Metabolism ; Insight into disease pathogenesis or mechanism of therapy ; September ; Although infection is a common precipitating factor for both DKA and HHS, patients can be normothermic or even hypothermic primarily because of peripheral vasodilation Severe hypothermia, if present, is a poor prognostic sign.

The abdominal pain usually resolves with correction of hyperglycemia and metabolic acidosis. The most common clinical presentation in patients with HHS is altered sensorium 4 , 8 , 11 , Physical examination reveals signs of dehydration with loss of skin turgor, weakness, tachycardia, and hypotension.

Fever due to underlying infection is common, and signs of acidosis Kussmaul breathing, acetone breath are usually absent. In some patients, focal neurologic signs hemiparesis, hemianopsia and seizures partial motor seizures more common than generalized may be the dominant clinical features 1 , 4 , 6 , 8.

The initial laboratory evaluation of patients with suspected DKA or HHS should include determination of plasma glucose, blood urea nitrogen, creatinine, serum ketones, electrolytes with calculated anion gap , osmolality, urinalysis, urine ketones by dipstick, as well as initial arterial blood gases and complete blood count with differential.

An electrocardiogram, chest X-ray, and urine, sputum, or blood cultures should also be obtained, if clinically indicated. HbA 1c may be useful in determining whether this acute episode is the culmination of an evolutionary process in previously undiagnosed or poorly controlled diabetes or a truly acute episode in an otherwise well-controlled patient.

The diagnostic criteria for DKA and HHS are shown in Table 1. DKA consists of the biochemical triad of hyperglycemia, ketonemia, and metabolic acidosis. Accumulation of ketoacids results in an increased anion gap metabolic acidosis.

The severity of DKA is classified as mild, moderate, or severe based on the severity of metabolic acidosis blood pH, bicarbonate, ketones and the presence of altered mental status 1. Significant overlap between DKA and HHS has been reported in more than one-third of patients 1 , 2 , The majority of patients with hyperglycemic emergencies present with leukocytosis proportional to blood ketone body concentration 2 , The admission serum sodium is usually low because of the osmotic flux of water from the intracellular to the extracellular space in the presence of hyperglycemia.

An increase in serum sodium concentration in the presence of hyperglycemia indicates a rather profound degree of water loss. Unless the plasma is cleared of chylomicrons, pseudonormoglycemia and pseudohyponatremia may occur in DKA 37 , Serum potassium concentration may be elevated because of an extracellular shift of potassium caused by insulin deficiency, hypertonicity, and acidemia 3 , 10 , Patients with low normal or low serum potassium concentration on admission have severe total-body potassium deficiency and require very careful cardiac monitoring and more vigorous potassium replacement, because treatment lowers potassium further and can provoke cardiac dysrhythmia.

The classic work of Atchley et al. Studies on serum osmolality and mental alteration have established a positive linear relationship between osmolality and mental obtundation Amylase levels are elevated in the majority of patients with DKA, but this may be due to nonpancreatic sources, such as the parotid gland A serum lipase determination may be beneficial in the differential diagnosis of pancreatitis; however, lipase could also be elevated in DKA.

Finally, abnormal acetoacetate levels may falsely elevate serum creatinine if the clinical laboratory uses a colorometric method for the creatinine assay Not all patients with ketoacidosis have DKA. DKA must also be distinguished from other causes of high anion gap metabolic acidosis, including lactic acidosis; ingestion of drugs such as salicylate, methanol, ethylene glycol, and paraldehyde; and chronic renal failure.

A clinical history of previous drug abuse or metformin use should be sought. Measurement of blood lactate, serum salicylate, and blood methanol level can be helpful in these situations. Ethylene glycol antifreeze is suggested by the presence of calcium oxalate and hippurate crystals in the urine.

Paraldehyde ingestion is indicated by its characteristic strong odor on the breath. Because these intoxicants are low—molecular-weight organic compounds, they can produce an osmolar gap in addition to the anion gap acidosis 10 , A recent report 44 suggested a relationship between low carbohydrate dietary intake and metabolic acidosis.

Finally, four case reports have shown that patients with undiagnosed acromegaly may present with DKA as the primary manifestation of their disease 45 — Successful treatment of DKA and HHS requires correction of dehydration, hyperglycemia, and electrolyte imbalances; identification of comorbid precipitating events; and above all, frequent patient monitoring.

Protocols for the management of patients with DKA and HHS are summarized in Figs. Initial fluid therapy is directed toward expansion of the intravascular and extra vascular volume and restoration of renal perfusion. In the absence of cardiac compromise, isotonic saline 0. The subsequent choice for fluid replacement depends on the state of hydration, serum electrolyte levels, and urinary output.

In general, 0. Successful progress with fluid replacement is judged by hemodynamic monitoring improvement in blood pressure , measurement of fluid input and output, laboratory values, and clinical examination. Fluid replacement should correct estimated deficits within the first 24 h.

In patients with renal or cardiac compromise, monitoring of serum osmolality and frequent assessment of cardiac, renal, and mental status must be performed during fluid resuscitation to avoid iatrogenic fluid overload 1 , 3 , 4 , 10 , 12 , 16 , Adequate rehydration with subsequent correction of the hyperosmolar state has been shown to result in a more robust response to low-dose insulin therapy If plasma glucose does not decrease by 50—75 mg from the initial value in the first hour, the insulin infusion may be doubled every hour until a steady glucose decline is achieved.

Thereafter, the rate of insulin administration or the concentration of dextrose may need to be adjusted to maintain the above-glucose values until acidosis in DKA or mental obtundation and hyperosmolality in HHS are resolved.

Prospective and randomized studies have reported on the efficacy and cost effectiveness of subcutaneous rapid-acting insulin analogs in the management of patients with uncomplicated DKA.

Patients treated with subcutaneous rapid-acting insulin received an initial injection of 0. There were no differences in length of hospital stay, total amount of insulin administration until resolution of hyperglycemia or ketoacidosis, or number of hypoglycemic events among treatment groups.

In addition, the use of insulin analogs allowed treatment of DKA in general wards or in the emergency department, avoiding admission to an intensive care unit. Ketonemia typically takes longer to clear than hyperglycemia. Direct measurement of β-OHB in the blood is the preferred method for monitoring DKA and has become more convenient with the recent development of bedside meters capable of measuring whole-blood β-OHB The nitroprusside method, which is used in clinical chemistry laboratories, measures acetoacetic acid and acetone; however, β-OHB, the strongest and most prevalent acid in DKA, is not measured by the nitroprusside method.

During therapy, β-OHB is converted to acetoacetic acid, which may lead the clinician to believe that ketosis has worsened Therefore, assessments of urinary or serum ketone levels by the nitroprusside method should not be used as an indicator of response to therapy. During therapy for DKA or HHS, blood should be drawn every 2—4 h for determination of serum electrolytes, glucose, blood urea nitrogen, creatinine, osmolality, and venous pH for DKA.

Generally, repeat arterial blood gases are unnecessary during the treatment of DKA in hemodynamically stable patients.

Since venous pH is only 0. When the patient is able to eat, a multiple-dose insulin schedule should be started that uses a combination of short- or rapid-acting and intermediate- or long-acting insulin as needed to control plasma glucose.

Intravenous insulin infusion should be continued for 1—2 h after the subcutaneous insulin is given to ensure adequate plasma insulin levels. An abrupt discontinuation of intravenous insulin coupled with a delayed onset of a subcutaneous insulin regimen may lead to hyperglycemia or recurrence of ketoacidosis.

If the patient is to remain n. Patients with known diabetes may be given insulin at the dose they were receiving before the onset of DKA or HHS.

In insulin-naïve patients, a multidose insulin regimen should be started at a dose of 0. However, good clinical judgment and frequent glucose assessment are vital in initiating a new insulin regimen in insulin-naïve patients. Despite total-body potassium depletion 40 , 57 , mild to moderate hyperkalemia is not uncommon in patients with hyperglycemic crises.

Insulin therapy, correction of acidosis, and volume expansion decrease serum potassium concentration. Rarely, DKA patients may present with significant hypokalemia.

Bicarbonate use in DKA remains controversial However, the administration of bicarbonate may be associated with several deleterious effects including an increased risk of hypokalemia 59 , decreased tissue oxygen uptake, and cerebral edema 60 , A prospective randomized study in 21 patients failed to show either beneficial or deleterious changes in morbidity or mortality with bicarbonate therapy in DKA patients with an admission arterial pH between 6.

The average pH in the bicarbonate group was 7. Therefore, if the pH is 6. Bicarbonate as well as insulin therapy lowers serum potassium; therefore, potassium supplementation should be maintained in the intravenous fluid as described above and carefully monitored. See Fig. Thereafter, venous pH should be assessed every 2 h until the pH rises to 7.

See reference 1 for further review. Despite whole-body phosphate deficits in DKA that average 1. Phosphate concentration decreases with insulin therapy. Prospective randomized studies 63 , 64 have failed to show any beneficial effect of phosphate replacement on the clinical outcome in DKA, and overzealous phosphate therapy can cause severe hypocalcemia 63 , Therefore, the routine use of phosphate in the treatment of DKA or HHS has resulted in no clinical benefit to the patient The most common complications of DKA and HHS include hypoglycemia and hypokalemia due to overzealous treatment with insulin.

Low potassium may also occur as a result of treatment of acidosis with bicarbonate. Commonly, patients recovering from DKA develop a transient hyperchloremic non—anion gap acidosis 68 — The hyperchloremic acidosis is caused by the loss of large quantities of ketoanions that occur during the development of DKA.

Because ketoanions are metabolized with regeneration of bicarbonate, the prior loss of ketoacid anions in the urine hinders regeneration of bicarbonate during treatment Other mechanisms include the administration of intravenous fluids containing chloride that exceeds the plasma chloride concentration and the intracellular shifts of NaHCO 3 during correction of DKA Cerebral edema is a rare but frequently fatal complication of DKA, occurring in 0.

It is most common in children with newly diagnosed diabetes, but it has been reported in children with known diabetes and in young people in their twenties 72 — Fatal cases of cerebral edema have also been reported with HHS.

Clinically, cerebral edema is characterized by deterioration in the level of consciousness, lethargy, decreased arousal, and headache. Neurological deterioration may be rapid, with seizures, incontinence, pupillary changes, bradycardia, and respiratory arrest. These symptoms progress as brain stem herniation occurs.

The progression may be so rapid that papilledema is not found. Although the mechanism of cerebral edema is not known, it may result from osmotically driven movement of water into the central nervous system when plasma osmolality declines too rapidly with the treatment of DKA or HHS 72 — However, a recent study 75 using magnetic resonance imaging to assess cerebral water diffusion and cerebral vascular perfusion during the treatment of 14 children with DKA found that the cerebral edema was not a function of cerebral tissue edema but rather a function of increased cerebral perfusion.

There is a lack of information on the morbidity associated with cerebral edema in adult patients; therefore, any recommendations for adult patients are based on clinical judgment rather than scientific evidence.

Hypoxemia and, rarely, noncardiogenic pulmonary edema may complicate the treatment of DKA. Hypoxemia is attributed to a reduction in colloid osmotic pressure that results in increased lung water content and decreased lung compliance Patients with DKA who have a widened alveolo-arteriolar oxygen gradient noted on initial blood gas measurement or with pulmonary rales on physical examination appear to be at higher risk for the development of pulmonary edema.

Many cases of DKA and HHS can be prevented by better access to medical care, proper education, and effective communication with a health care provider during an intercurrent illness. The observation that stopping insulin for economic reasons is a common precipitant of DKA in urban African Americans and Hispanics 2 , 76 , 77 underscores the need for our health care delivery systems to address this problem, which is costly and clinically serious Sick-day management should be reviewed periodically with all patients.

It should include specific information on 1 when to contact the health care provider, 2 blood glucose goals and the use of supplemental short- or rapid-acting insulin during illness, 3 means to suppress fever and treat infection, and 4 initiation of an easily digestible liquid diet containing carbohydrates and salt.

Most importantly, the patient should be advised to never discontinue insulin and to seek professional advice early in the course of the illness.

Adequate supervision and help from staff or family may prevent many of the admissions for HHS due to dehydration among elderly individuals who are unable to recognize or treat this evolving condition. Better education of caregivers as well as patients regarding signs and symptoms of new-onset diabetes; conditions, procedures, and medications that worsen diabetes control; and the use of glucose monitoring could potentially decrease the incidence and severity of HHS.

The annual incidence rate for DKA from population-based studies ranges from 4. Significant resources are spent on the cost of hospitalization. Based on an annual average of , hospitalizations for DKA in the U. Many of these hospitalizations could be avoided by devoting adequate resources to apply the measures described above.

Because repeated admissions for DKA are estimated to drain approximately one of every two health care dollars spent on adult patients with type 1 diabetes, resources need to be redirected toward prevention by funding better access to care and educational programs tailored to individual needs, including ethnic and personal health care beliefs.

In addition, resources should be directed toward the education of primary care providers and school personnel so that they can identify signs and symptoms of uncontrolled diabetes and new-onset diabetes can be diagnosed earlier.

This has been shown to decrease the incidence of DKA at the onset of diabetes A recent study from a city hospital reports that active cocaine use is an independent risk factor for recurrent DKA Protocol for the management of adult patients with DKA.

Normal laboratory values vary; check local lab normal ranges for all electrolytes. Begin 1 liter of 0. Obtain electrocardiogram, chest X-ray, and specimens for bacterial cultures, as needed.

Adapted from ref. Protocol for the management of adult patients with HHS. Diagnostic criteria and typical total body deficits of water and electrolytes in DKA and HHS. Per kg body wt. Data adapted from refs.

Studies cited by the authors were supported in part by USPHS grants RR to the General Clinical Research Center and AM , training grant AM of the National Institutes of Health, and grants from Novo-Nordisk, Eli Lilly, the American Diabetes Association, and the Abe Goodman Fund.

The initial draft of this position statement was prepared by the authors as listed above. The manuscript was then peer-reviewed, modified, and approved by the Professional Practice Committee and the Executive Committee, March The recommendations in this article are based on the evidence reviewed in the following publication: Management of hyperglycemic crises in patients with diabetes Technical Review.

Diabetes Care —, , as well as subsequent peer-reviewed publications since A table elsewhere in this issue shows conventional and Système International SI units and conversion factors for many substances. Sign In or Create an Account. Search Dropdown Menu. header search search input Search input auto suggest.

filter your search All Content All Journals Diabetes Care. Advanced Search. User Tools Dropdown. Sign In. Skip Nav Destination Close navigation menu Article navigation. Volume 29, Issue Previous Article Next Article. NOTE ADDED IN PROOF—. Article Information. Article Navigation.

Hyperglycemic Crises in Adult Patients With Diabetes : A consensus statement from the American Diabetes Association Abbas E. Kitabchi, PHD, MD ; Abbas E. Kitabchi, PHD, MD. This Site. Google Scholar. Guillermo E. Umpierrez, MD ; Guillermo E. Umpierrez, MD. Mary Beth Murphy, RN, MS, CDE, MBA ; Mary Beth Murphy, RN, MS, CDE, MBA.

Robert A. Kreisberg, MD Robert A. Kreisberg, MD. Address correspondence and reprint requests to Dr. Kitabchi, Director, Division of Endocrinology, Diabetes and Metabolism, University of Tennessee Health Science Center, Court Ave.

E-mail: akitabchi utmem. Diabetes Care ;29 12 — Get Permissions. toolbar search Search Dropdown Menu. toolbar search search input Search input auto suggest.

Figure 1—. View large Download slide. Figure 2—. Figure 3—. Table 1— Diagnostic criteria and typical total body deficits of water and electrolytes in DKA and HHS. View Large. Kitabchi AE, Umpierrez GE, Murphy MB, Barrett EJ, Kreisberg RA, Malone JI, Wall BM: Management of hyperglycemic crises in patients with diabetes Technical Review.

Diabetes Care. Umpierrez GE, Kelly JP, Navarrete JE, Casals MM, Kitabchi AE: Hyperglycemic crises in urban blacks. Arch Intern Med. DeFronzo RA, Matzuda M, Barret E: Diabetic ketoacidosis: a combined metabolic-nephrologic approach to therapy.

Schedule Appointment. East Orlando Quadrangle Crisos. Orlando, FL Call Hyperglycemic crisis and hypokalemia Nona Tavistock Lakes Blvd. Health Questionnaire. Recent studies show a connection between potassium levels in the body and the prevalence of diabetes mellitus.

Author: Shaktit

5 thoughts on “Hyperglycemic crisis and hypokalemia

  1. Jetzt kann ich an der Diskussion nicht teilnehmen - es gibt keine freie Zeit. Aber bald werde ich unbedingt schreiben dass ich denke.

Leave a comment

Yours email will be published. Important fields a marked *

Design by ThemesDNA.com